BURZYKOWSKI, Tomasz

Full Name
BURZYKOWSKI, Tomasz
Email
tomasz.burzykowski@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Internal UHasselt:  BUYSE, Marc
Date Issued:  [2020 TO 2023]

Results 1-11 of 11 (Search time: 0.003 seconds).

Issue DateTitleContributor(s)TypeCat.
12023Trial Design for Cancer Immunotherapy: A Methodological ToolkitSaad, Everardo D.; Coart, Elisabeth; DELTUVAITE-THOMAS, Vaiva; GARCIA BARRADO, Leandro; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
22023Minimization in randomized clinical trialsCoart, Elisabeth; Bamps, Perrine; Quinaux, Emmanuel; Sturbois, Geneviève; Saad, Everardo D; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
32023Generalized pairwise comparisons for censored data: An overviewDELTUVAITE-THOMAS, Vaiva; VERBEECK, Johan; BURZYKOWSKI, Tomasz; BUYSE, Marc; Tournigand, Christophe; MOLENBERGHS, Geert; THAS, OlivierJournal ContributionA1
42022Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials MethodologyGoldberg, Richard M.; Adams, Richard; BUYSE, Marc; Eng, Cathy; Grothey, Axel; Andre, Thierry; Sobrero, Alberto F.; Lichtman, Stuart M.; Benson, Al B.; Punt, Cornelis J. A.; Maughan, Tim; BURZYKOWSKI, Tomasz; Sommeijer, Dirkje; Saad, Everardo D.; Shi, Qian; Coart, Elisabeth; Chibaudel, Benoist; Koopman, Miriam; Schmoll, Hans-Joachim; Yoshino, Takayuki; Taieb, Julien; Tebbutt, Niall C.; Zalcberg, John; Tabernero, Josep; Van Cutsem , Eric; Matheson, Alastair; de Gramont, AimeryJournal ContributionA1
52022Surrogacy Beyond Prognosis: The Importance of “Trial-Level” SurrogacyBUYSE, Marc; Saad, Everardo D.; BURZYKOWSKI, Tomasz; Regan, Meredith M.; Sweeney, Christopher S.Journal ContributionA1
62022The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustrationJamoul, Corinne; Collette, Laurence; Coart, Elisabeth; D'Hollander, Koenraad; BURZYKOWSKI, Tomasz; Saad, Everardo D; BUYSE, MarcJournal ContributionA1
72022Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpointBarrado, Leandro Garcia; BURZYKOWSKI, Tomasz; LEGRAND, Catherine; BUYSE, MarcJournal ContributionA1
82021Evaluation of surrogate endpointsMOLENBERGHS, Geert; SHKEDY, Ziv; BURZYKOWSKI, Tomasz; BUYSE, Marc; ALONSO ABAD, Ariel; VAN DER ELST, WimBook SectionB2
92020Unbiasedness and efficiency of non-parametric and UMVUE estimators of the probabilistic index and related statisticsVERBEECK, Johan; DELTUVAITE-THOMAS, Vaiva; BERCKMOES, Ben; BURZYKOWSKI, Tomasz; AERTS, Marc; THAS, Olivier; BUYSE, Marc; MOLENBERGHS, GeertJournal ContributionA1
102020Progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in advanced/recurrent gastric cancer (AGC) treatment: Individual-patient-data (IPD) based meta-analysis of randomized trialsOba, Koji; Paoletto, Xavier; Bang, Yung-Jue; Bouche, Olivier; Ducreux, Michel; Michiels, Stefan; Moehler, MarkusH; Morita, Satoshi; Ohashi, Yasuo; Sakamoto, Junichi; Sasako, Mitsuru; Shitara, Kohei; Van Cutsem, Eric; BUYSE, Marc; BURZYKOWSKI, TomaszJournal ContributionM
112020Meta-analytic approach to evaluation of surrogate endpointsBURZYKOWSKI, Tomasz; BUYSE, Marc; MOLENBERGHS, Geert; ALONSO ABAD, Ariel; VAN DER ELST, Wim; SHKEDY, ZivBook SectionB2